Regulatory Pressures And Oversupply Will Undermine Indian Healthcare
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 10 Analysts
Published
17 Jul 25
Updated
21 Aug 25
AnalystLowTarget's Fair Value
₹449.63
33.7% overvalued intrinsic discount21 Aug
₹601.00
1Y
46.5%7D
-2.8%1Y
46.5%7D
-2.8%